Recent News

CMS revised Medicare coverage criteria for therapeutic CGMs. Most notably, eliminating a requirement that beneficiaries use four fingerstick tests per day prior to accessing CGM. Effective July 18, 2021.

Centers for Medicare & Medicaid Services

Real-time CGM lowers HbA1c, reduces ED visits in insulin-treated diabetes

Endocrine Today

Featured Publications

		Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes The Journal of the American Medical Association
		Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized controlled trial The Lancet
		Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial The Journal of the American Medical Association
		Real-World Evidence of Real-Time CGM (rtCGM) Use and Healthcare Cost Implications Diabetes Technology & Therapeutics

Featured Resource

CGM Payer Insights on Optimizing Outcomes in Insulin-Treated T1 and T2D via Evidence-Based Coverage Criteria with Real-Time CGM

Advisory Board

Vanita Pindolia, PharmD, BCPS, MBA

(Formerly) Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan
Read More

Joseph Albright, PharmD

Manager, Clinical Pharmacy Services
BlueCross BlueShield North Carolina
Read More

Jeffrey D. Dunn, PharmD, MBA

(Formerly) Vice President, Clinical Strategy and Programs and Industry Relations
MagellanRx Management
Read More

Daniel DeSalvo, MD

Assistant Professor of Pediatrics
Director of Strategic Collaboration
Diabetes Clinic CPT Co-Director
Section of Pediatric Diabetes & Endocrinology
Baylor College of Medicine/Texas Children's Hospital
Read More

Latest Expert Interview

Archived Interviews

Stay Connected

Tweets by @NHF_Hemophilia

ManagedCareCGM

This site is intended for managed care professionals in the U.S.

Continuous Glucose Monitoring

CMS expands Medicare coverage for CGM, eliminating requirement of 4 fingersticks per day prior to accessing CGM

Featured Article

"Our real-world study found that in patients with insulin-treated diabetes, initiating a continuous glucose monitor substantially improved blood glucose control and cut the rate of emergency room visits for hypoglycemia in half,” Andrew J. Karter, PhD

New Free On-Demand CME/CNE/CPE Activity:

Real-World, Value-Added Benefits of Real-Time CGM in an Integrated Health System

Highlights from AMCP 2021

Improving Quality Metrics and Reducing Cost of Care with Access to Real-Time Continuous Glucose Monitoring

Recent News

CMS revised Medicare coverage criteria for therapeutic CGMs. Most notably, eliminating a requirement that beneficiaries use four fingerstick tests per day prior to accessing CGM. Effective July 18, 2021.

Centers for Medicare & Medicaid Services

Real-time CGM lowers HbA1c, reduces ED visits in insulin-treated diabetes

Endocrine Today

Featured Publications

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes

The Journal of the American Medical Association

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized controlled trial

The Lancet

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial